{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:43:12Z","timestamp":1793371392416,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41590-026-02473-y","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:03:12Z","timestamp":1774260192000},"page":"1039-1052","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Engineering NK and T cells with metabolite-sensing receptors to target solid tumors"],"prefix":"10.1038","volume":"27","author":[{"given":"Young-Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min K.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2080-5450","authenticated-orcid":false,"given":"Chang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4416-0475","authenticated-orcid":false,"given":"Olivia","family":"Laveroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reece Villarin","family":"Akana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Frombach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-386X","authenticated-orcid":false,"given":"Livnat","family":"Jerby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"2473_CR1","doi-asserted-by":"publisher","first-page":"109821","DOI":"10.1016\/j.biopha.2020.109821","volume":"124","author":"S Tan","year":"2020","unstructured":"Tan, S., Li, D. & Zhu, X. Cancer immunotherapy: pros, cons and beyond. Biomed. Pharmacother. 124, 109821 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"2473_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13287-020-02128-1","volume":"12","author":"F Marofi","year":"2021","unstructured":"Marofi, F. et al. CAR T cells in solid tumors: challenges and opportunities. Stem Cell Res. Ther. 12, 81 (2021).","journal-title":"Stem Cell Res. Ther."},{"key":"2473_CR3","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/s41591-019-0654-5","volume":"25","author":"D Liu","year":"2019","unstructured":"Liu, D. et al. Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nat. Med. 25, 1916\u20131927 (2019).","journal-title":"Nat. Med."},{"key":"2473_CR4","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.tcb.2020.08.002","volume":"30","author":"A Shellard","year":"2020","unstructured":"Shellard, A. & Mayor, R. All roads lead to directional cell migration. Trends Cell Biol. 30, 852\u2013868 (2020).","journal-title":"Trends Cell Biol."},{"key":"2473_CR5","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41577-021-00507-0","volume":"21","author":"DJ Fowell","year":"2021","unstructured":"Fowell, D. J. & Kim, M. The spatio-temporal control of effector T cell migration. Nat. Rev. Immunol. 21, 582\u2013596 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"2473_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nri.2015.16","volume":"16","author":"MF Krummel","year":"2016","unstructured":"Krummel, M. F., Bartumeus, F. & G\u00e9rard, A. T cell migration, search strategies and mechanisms. Nat. Rev. Immunol. 16, 193\u2013201 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"2473_CR7","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cell.2019.07.044","volume":"178","author":"MB Dong","year":"2019","unstructured":"Dong, M. B. et al. Systematic immunotherapy target discovery using genome-scale in vivo CRISPR screens in CD8+ T cells. Cell 178, 1189\u20131204 (2019).","journal-title":"Cell"},{"key":"2473_CR8","doi-asserted-by":"crossref","unstructured":"Peng, L. et al. In vivo AAV\u2013SB-CRISPR screens of tumor-infiltrating primary NK cells identify genetic checkpoints of CAR-NK therapy. Nat. Biotechnol.43, 752\u2013761 (2025).","DOI":"10.1038\/s41587-024-02282-4"},{"key":"2473_CR9","doi-asserted-by":"crossref","unstructured":"Schmidt, R. et al. CRISPR activation and interference screens decode stimulation responses in primary human T cells. Science 375, eabj4008 (2022).","DOI":"10.1126\/science.abj4008"},{"key":"2473_CR10","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41586-022-04494-7","volume":"603","author":"M Legut","year":"2022","unstructured":"Legut, M. et al. A genome-scale screen for synthetic drivers of T cell proliferation. Nature 603, 728\u2013735 (2022).","journal-title":"Nature"},{"key":"2473_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nature12988","volume":"506","author":"P Zhou","year":"2014","unstructured":"Zhou, P. et al. In vivo discovery of immunotherapy targets in the tumour microenvironment. Nature 506, 52\u201357 (2014).","journal-title":"Nature"},{"key":"2473_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fimmu.2016.00091","volume":"7","author":"H Klingemann","year":"2016","unstructured":"Klingemann, H., Boissel, L. & Toneguzzo, F. Natural killer cells for immunotherapy\u2014advantages of the NK-92 cell line over blood NK cells. Front. Immunol. 7, 91 (2016).","journal-title":"Front. Immunol."},{"key":"2473_CR13","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.jcyt.2017.07.008","volume":"19","author":"M Boyiadzis","year":"2017","unstructured":"Boyiadzis, M. et al. Phase 1 clinical trial of adoptive immunotherapy using \u2018off-the-shelf\u2019 activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia. Cytotherapy 19, 1225\u20131232 (2017).","journal-title":"Cytotherapy"},{"key":"2473_CR14","doi-asserted-by":"publisher","first-page":"89256","DOI":"10.18632\/oncotarget.19204","volume":"8","author":"BA Williams","year":"2017","unstructured":"Williams, B. A. et al. A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy. Oncotarget 8, 89256\u201389268 (2017).","journal-title":"Oncotarget"},{"key":"2473_CR15","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","volume":"39","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer. Cancer Cell 39, 1578\u20131593 (2021).","journal-title":"Cancer Cell"},{"key":"2473_CR16","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1016\/j.cell.2023.07.034","volume":"186","author":"F Tang","year":"2023","unstructured":"Tang, F. et al. A pan-cancer single-cell panorama of human natural killer cells. Cell 186, 4235\u20134251 (2023).","journal-title":"Cell"},{"key":"2473_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0844-5","volume":"16","author":"G Finak","year":"2015","unstructured":"Finak, G. et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 278 (2015).","journal-title":"Genome Biol."},{"key":"2473_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"2473_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14136","volume":"517","author":"S Konermann","year":"2015","unstructured":"Konermann, S. et al. Genome-scale transcriptional activation by an engineered CRISPR\u2013Cas9 complex. Nature 517, 583\u2013588 (2015).","journal-title":"Nature"},{"key":"2473_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1806009","volume":"9","author":"D Qin","year":"2020","unstructured":"Qin, D. et al. Potential lung attack and lethality generated by EpCAM-specific CAR-T cells in immunocompetent mouse models. Oncoimmunology 9, 1806009 (2020).","journal-title":"Oncoimmunology"},{"key":"2473_CR21","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/mt.2010.24","volume":"18","author":"RA Morgan","year":"2010","unstructured":"Morgan, R. A. et al. Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol. Ther. 18, 843\u2013851 (2010).","journal-title":"Mol. Ther."},{"key":"2473_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"2473_CR23","doi-asserted-by":"publisher","first-page":"D1438","DOI":"10.1093\/nar\/gkad944","volume":"52","author":"SD Harding","year":"2024","unstructured":"Harding, S. D. et al. The IUPHAR\/BPS Guide to Pharmacology in 2024. Nucleic Acids Res. 52, D1438\u2013D1449 (2024).","journal-title":"Nucleic Acids Res."},{"key":"2473_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-11-44","volume":"11","author":"D McHugh","year":"2010","unstructured":"McHugh, D. et al. N-Arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci. 11, 44 (2010).","journal-title":"BMC Neurosci."},{"key":"2473_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature10226","volume":"475","author":"C Liu","year":"2011","unstructured":"Liu, C. et al. Oxysterols direct B-cell migration through EBI2. Nature 475, 519\u2013523 (2011).","journal-title":"Nature"},{"key":"2473_CR26","doi-asserted-by":"publisher","first-page":"10684","DOI":"10.1074\/jbc.M112.420042","volume":"288","author":"M Suzuki","year":"2013","unstructured":"Suzuki, M. et al. Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor. J. Biol. Chem. 288, 10684\u201310691 (2013).","journal-title":"J. Biol. Chem."},{"key":"2473_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/jb\/mvs011","volume":"151","author":"H Kitamura","year":"2012","unstructured":"Kitamura, H. et al. GPR34 is a receptor for lysophosphatidylserine with a fatty acid at the sn-2 position. J. Biochem. 151, 511\u2013518 (2012).","journal-title":"J. Biochem."},{"key":"2473_CR28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature10280","volume":"475","author":"S Hannedouche","year":"2011","unstructured":"Hannedouche, S. et al. Oxysterols direct immune cell migration via EBI2. Nature 475, 524\u2013527 (2011).","journal-title":"Nature"},{"key":"2473_CR29","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.4049\/jimmunol.0803055","volume":"182","author":"IU Schraufstatter","year":"2009","unstructured":"Schraufstatter, I. U., DiScipio, R. G., Zhao, M. & Khaldoyanidi, S. K. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1\/2 phosphorylation. J. Immunol. 182, 3827\u20133836 (2009).","journal-title":"J. Immunol."},{"key":"2473_CR30","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.4049\/jimmunol.1101262","volume":"187","author":"LM Kelly","year":"2011","unstructured":"Kelly, L. M., Pereira, J. P., Yi, T., Xu, Y. & Cyster, J. G. EBI2 guides serial movements of activated B cells and ligand activity is detectable in lymphoid and nonlymphoid tissues. J. Immunol. 187, 3026\u20133032 (2011).","journal-title":"J. Immunol."},{"key":"2473_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1084\/jem.20041277","volume":"201","author":"I Migeotte","year":"2005","unstructured":"Migeotte, I. et al. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J. Exp. Med. 201, 83\u201393 (2005).","journal-title":"J. Exp. Med."},{"key":"2473_CR32","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.bbrc.2006.01.069","volume":"341","author":"T Sugo","year":"2006","unstructured":"Sugo, T. et al. Identification of a lysophosphatidylserine receptor on mast cells. Biochem. Biophys. Res. Commun. 341, 1078\u20131087 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2473_CR33","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1084\/jem.20150225","volume":"212","author":"N Chiang","year":"2015","unstructured":"Chiang, N., Dalli, J., Colas, R. A. & Serhan, C. N. Identification of resolvin D2 receptor mediating resolution of infections and organ protection. J. Exp. Med. 212, 1203\u20131217 (2015).","journal-title":"J. Exp. Med."},{"key":"2473_CR34","doi-asserted-by":"publisher","first-page":"7906","DOI":"10.1074\/jbc.273.14.7906","volume":"273","author":"S An","year":"1998","unstructured":"An, S., Bleu, T., Hallmark, O. G. & Goetzl, E. J. Characterization of a novel subtype of human G-protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem. 273, 7906\u20137910 (1998).","journal-title":"J. Biol. Chem"},{"key":"2473_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0955-0674(97)80059-2","volume":"9","author":"WH Moolenaar","year":"1997","unstructured":"Moolenaar, W. H., Kranenburg, O., Postma, F. R. & Zondag, G. C. Lysophosphatidic acid: G-protein signalling and cellular responses. Curr. Opin. Cell Biol. 9, 168\u2013173 (1997).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2473_CR36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nsmb.3014","volume":"22","author":"WK Kroeze","year":"2015","unstructured":"Kroeze, W. K. et al. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22, 362\u2013369 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2473_CR37","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1042\/BJ20112090","volume":"443","author":"L Ritscher","year":"2012","unstructured":"Ritscher, L. et al. The ligand specificity of the G-protein-coupled receptor GPR34. Biochem. J. 443, 841\u2013850 (2012).","journal-title":"Biochem. J."},{"key":"2473_CR38","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3389\/fimmu.2019.01473","volume":"10","author":"TK Darling","year":"2019","unstructured":"Darling, T. K. & Lamb, T. J. Emerging roles for Eph receptors and ephrin ligands in immunity. Front. Immunol. 10, 1473 (2019).","journal-title":"Front. Immunol."},{"key":"2473_CR39","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","volume":"23","author":"A Christofides","year":"2022","unstructured":"Christofides, A. et al. The complex role of tumor-infiltrating macrophages. Nat. Immunol. 23, 1148\u20131156 (2022).","journal-title":"Nat. Immunol."},{"key":"2473_CR40","doi-asserted-by":"crossref","unstructured":"Yeh, C. Y. et al. Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancer. Nat. Immunol.25, 1943\u20131958 (2024).","DOI":"10.1038\/s41590-024-01943-5"},{"key":"2473_CR41","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.immuni.2019.04.001","volume":"50","author":"AP Baptista","year":"2019","unstructured":"Baptista, A. P. et al. The chemoattractant receptor EBI2 drives intranodal naive CD4+ T cell peripheralization to promote effective adaptive immunity. Immunity 50, 1188\u20131201 (2019).","journal-title":"Immunity"},{"key":"2473_CR42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.immuni.2017.11.020","volume":"48","author":"J Emg\u00e5rd","year":"2018","unstructured":"Emg\u00e5rd, J. et al. Oxysterol sensing through the receptor GPR183 promotes the lymphoid-tissue-inducing function of innate lymphoid cells and colonic inflammation. Immunity 48, 120\u2013132 (2018).","journal-title":"Immunity"},{"key":"2473_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aal5237","volume":"2","author":"E Lu","year":"2017","unstructured":"Lu, E., Dang, E. V., McDonald, J. G. & Cyster, J. G. Distinct oxysterol requirements for positioning naive and activated dendritic cells in the spleen. Sci. Immunol. 2, eaal5237 (2017).","journal-title":"Sci. Immunol."},{"key":"2473_CR44","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.cell.2016.11.038","volume":"167","author":"A Dixit","year":"2016","unstructured":"Dixit, A. et al. Perturb-seq: dissecting molecular circuits with scalable single-cell RNA profiling of pooled genetic screens. Cell 167, 1853\u20131866 (2016).","journal-title":"Cell"},{"key":"2473_CR45","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41587-020-0470-y","volume":"38","author":"JM Replogle","year":"2020","unstructured":"Replogle, J. M. et al. Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing. Nat. Biotechnol. 38, 954\u2013961 (2020).","journal-title":"Nat. Biotechnol."},{"key":"2473_CR46","doi-asserted-by":"crossref","unstructured":"Kim, J.-S.et al. GPR183 regulates 7\u03b1,25-dihydroxycholesterol-induced oxiapoptophagy in L929 mouse fibroblast cell. Molecules 27, 4798 (2022).","DOI":"10.3390\/molecules27154798"},{"key":"2473_CR47","doi-asserted-by":"crossref","unstructured":"Trakkides, T.-O. et al. Oxidative stress increases endogenous complement-dependent inflammatory and angiogenic responses in retinal pigment epithelial cells independently of exogenous complement sources. Antioxidants 8, 548 (2019).","DOI":"10.3390\/antiox8110548"},{"key":"2473_CR48","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/0161-5890(89)90057-6","volume":"26","author":"W Vogt","year":"1989","unstructured":"Vogt, W., Damerau, B., von Zabern, I., Nolte, R. & Brunahl, D. Non-enzymic activation of the fifth component of human complement, by oxygen radicals. Some properties of the activation product, C5b-like C5. Mol. Immunol. 26, 1133\u20131142 (1989).","journal-title":"Mol. Immunol."},{"key":"2473_CR49","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1167\/iovs.10-5289","volume":"51","author":"G Tezel","year":"2010","unstructured":"Tezel, G. et al. Oxidative stress and the regulation of complement activation in human glaucoma. Invest. Ophthalmol. Vis. Sci. 51, 5071\u20135082 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2473_CR50","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nri3755","volume":"14","author":"JG Cyster","year":"2014","unstructured":"Cyster, J. G., Dang, E. V., Reboldi, A. & Yi, T. 25-Hydroxycholesterols in innate and adaptive immunity. Nat. Rev. Immunol. 14, 731\u2013743 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"2473_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","volume":"25","author":"R Arafeh","year":"2025","unstructured":"Arafeh, R., Shibue, T., Dempster, J. M., Hahn, W. C. & Vazquez, F. The present and future of the Cancer Dependency Map. Nat. Rev. Cancer 25, 59\u201373 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"2473_CR52","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"2473_CR53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.124.3215.269","volume":"124","author":"O Warburg","year":"1956","unstructured":"Warburg, O. On respiratory impairment in cancer cells. Science 124, 269\u2013270 (1956).","journal-title":"Science"},{"key":"2473_CR54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson, M. T., Janaki-Raman, S. & Schulze, A. Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer. Cell Metab. 31, 62\u201376 (2020).","journal-title":"Cell Metab."},{"key":"2473_CR55","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41568-023-00576-4","volume":"23","author":"J Schwenck","year":"2023","unstructured":"Schwenck, J. et al. Advances in PET imaging of cancer. Nat. Rev. Cancer 23, 474\u2013490 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"2473_CR56","first-page":"1815","volume":"42","author":"T Hara","year":"2001","unstructured":"Hara, T. 18F-Fluorocholine: a new oncologic PET tracer. J. Nucl. Med. 42, 1815 (2001).","journal-title":"J. Nucl. Med."},{"key":"2473_CR57","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2174\/1389201011314030006","volume":"14","author":"LM Deford-Watts","year":"2013","unstructured":"Deford-Watts, L. M., Mintz, A. & Kridel, S. J. The potential of 11C-acetate PET for monitoring the fatty acid synthesis pathway in tumors. Curr. Pharm. Biotechnol. 14, 300\u2013312 (2013).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"2473_CR58","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/d41573-020-00029-9","volume":"19","author":"ML Wojciechowicz","year":"2020","unstructured":"Wojciechowicz, M. L. & Ma\u2019ayan, A. GPR84: an immune response dial? Nat. Rev. Drug Discov. 19, 374 (2020).","journal-title":"Nat. Rev. Drug Discov"},{"key":"2473_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/srep32255","volume":"6","author":"C Flegel","year":"2016","unstructured":"Flegel, C. et al. Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18. Sci. Rep. 6, 32255 (2016).","journal-title":"Sci. Rep."},{"key":"2473_CR60","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1084\/jem.20140646","volume":"211","author":"X Wang","year":"2014","unstructured":"Wang, X., Sumida, H. & Cyster, J. G. GPR18 is required for a normal CD8\u03b1\u03b1 intestinal intraepithelial lymphocyte compartment. J. Exp. Med. 211, 2351\u20132359 (2014).","journal-title":"J. Exp. Med."},{"key":"2473_CR61","doi-asserted-by":"crossref","unstructured":"Sumida, H. & Cyster, J. G. G-protein coupled receptor 18 contributes to establishment of the CD8+ effector T cell compartment. Front. Immunol. 9, 660 (2018).","DOI":"10.3389\/fimmu.2018.00660"},{"key":"2473_CR62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203273119","volume":"119","author":"L Lou","year":"2022","unstructured":"Lou, L. et al. Mafba and Mafbb regulate microglial colonization of zebrafish brain via controlling chemotaxis receptor expression. Proc. Natl Acad. Sci. USA 119, e2203273119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2473_CR63","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.immuni.2021.05.007","volume":"54","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. GPR34-mediated sensing of lysophosphatidylserine released by apoptotic neutrophils activates type 3 innate lymphoid cells to mediate tissue repair. Immunity 54, 1123\u20131136 (2021).","journal-title":"Immunity"},{"key":"2473_CR64","doi-asserted-by":"crossref","unstructured":"Tam, H. et al. Phosphatidylserine phospholipase A1 enables GPR34-dependent immune cell accumulation in the peritoneal cavity. J. Exp. Med. 221, e20240992 (2024).","DOI":"10.1084\/jem.20240992"},{"key":"2473_CR65","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2016580118","volume":"118","author":"D Brownlie","year":"2021","unstructured":"Brownlie, D. et al. Expansions of adaptive-like NK cells with a tissue-resident phenotype in human lung and blood. Proc. Natl Acad. Sci. USA 118, e2016580118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2473_CR66","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.cell.2024.11.031","volume":"188","author":"KY Chen","year":"2025","unstructured":"Chen, K. Y. et al. Inflammation switches the chemoattractant requirements for naive lymphocyte entry into lymph nodes. Cell 188, 1019\u20131035 (2025).","journal-title":"Cell"},{"key":"2473_CR67","doi-asserted-by":"crossref","unstructured":"Ceglia, S. et al. An epithelial cell-derived metabolite tunes immunoglobulin A secretion by gut-resident plasma cells. Nat. Immunol. 24, 531\u2013544 (2023).","DOI":"10.1038\/s41590-022-01413-w"},{"key":"2473_CR68","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.immuni.2023.01.025","volume":"56","author":"M Frascoli","year":"2023","unstructured":"Frascoli, M. et al. Skin \u03b3\u03b4 T cell inflammatory responses are hardwired in the thymus by oxysterol sensing via GPR183 and calibrated by dietary cholesterol. Immunity 56, 562\u2013575 (2023).","journal-title":"Immunity"},{"key":"2473_CR69","doi-asserted-by":"crossref","unstructured":"Horlbeck, M. A. et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. eLife 5, e19760 (2016).","DOI":"10.7554\/eLife.19760"},{"key":"2473_CR70","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1073\/pnas.0710487105","volume":"105","author":"G Barnea","year":"2008","unstructured":"Barnea, G. et al. The genetic design of signaling cascades to record receptor activation. Proc. Natl Acad. Sci. USA 105, 64\u201369 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2473_CR71","doi-asserted-by":"publisher","first-page":"e20201529","DOI":"10.1084\/jem.20201529","volume":"218","author":"R-S Huang","year":"2021","unstructured":"Huang, R.-S., Lai, M.-C., Shih, H.-A. & Lin, S. A robust platform for expansion and genome editing of primary human natural killer cells. J. Exp. Med. 218, e20201529 (2021).","journal-title":"J. Exp. Med."},{"key":"2473_CR72","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","volume":"175","author":"L Jerby-Arnon","year":"2018","unstructured":"Jerby-Arnon, L. et al. A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade. Cell 175, 984\u2013997 (2018).","journal-title":"Cell"},{"key":"2473_CR73","first-page":"1438","volume":"5","author":"Y Chen","year":"2016","unstructured":"Chen, Y., Lun, A. T. L. & Smyth, G. K. From reads to genes to pathways: differential expression analysis of RNA-seq experiments using Rsubread and the edgeR quasi-likelihood pipeline. F1000Res. 5, 1438 (2016).","journal-title":"F1000Res."},{"key":"2473_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0843-6","volume":"16","author":"W Li","year":"2015","unstructured":"Li, W. et al. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biol. 16, 281 (2015).","journal-title":"Genome Biol."},{"key":"2473_CR75","doi-asserted-by":"publisher","DOI":"10.1140\/epjb\/e2013-40829-0","volume":"86","author":"L Waltman","year":"2013","unstructured":"Waltman, L. & van Eck, N. J. A smart local moving algorithm for large-scale modularity-based community detection. Eur. Phys. J. B 86, 471 (2013).","journal-title":"Eur. Phys. J. B"},{"key":"2473_CR76","doi-asserted-by":"publisher","unstructured":"Kim, Y.-M., Tsai, M. & Jerby, L. Redirecting NK and T cells to breast and ovarian cancer tumors via metabolite-sensing receptors. figshare https:\/\/doi.org\/10.6084\/m9.figshare.31302178 (2026).","DOI":"10.6084\/m9.figshare.31302178"},{"key":"2473_CR77","doi-asserted-by":"publisher","unstructured":"Tang, F. & Li, J. Datasets for the paper \u2018A pan-cancer single cell panorama of human natural killer cells\u2019. Zenodo https:\/\/doi.org\/10.5281\/zenodo.8275844 (2023).","DOI":"10.5281\/zenodo.8275844"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02473-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02473-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02473-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:03:11Z","timestamp":1777575791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02473-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2473"],"URL":"https:\/\/doi.org\/10.1038\/s41590-026-02473-y","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Stanford University has filed a patent application (PCT\/US2025\/023673) on the basis of this work, and Y.-M.K. and L.J. are named as inventors. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}